Early Genomic Testing for Inherited Bleeding Disorders
Recruiting
Early Phase 1
Interventional Study
Bleeding Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 212 (estimated)
- Sponsor
- Queen's University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators aim to test the introduction of genomic testing early in the diagnostic pathway for inherited bleeding disorders in patients who have not received a diagnosis after first-line testing.
The goal of this clinical trial is to test the introduction of genomic testing early in the diagnostic pathway for patients referred to Hematology for a suspected inherited bleeding disorder. The …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* New patient referred for abnormal bleeding.
* Hemostasis expert clinician determined abnormal bleeding history AND family history of bleeding
* OR no family history of bleeding but hemostasis expert clinician determined severe bleeding history.
Exclusion Criteria:
* Prior di…
Contacts